Education
About Us
Working with TipRanks
Follow Us
INNO-GENE Spolka Akcyjna (DE:WQ3)
FRANKFURT:WQ3
WQ3 Stock Chart & Stats
€0.38
€0.00(0.00%)
At close: 4:00 PM EST
€0.38
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.34 - €0.47
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€18.48M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)145.8
Beta0.33
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding33,581,080
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
WQ3 FAQ
What was INNO-GENE Spolka Akcyjna’s price range in the past 12 months?
INNO-GENE Spolka Akcyjna lowest stock price was €0.34 and its highest was €0.47 in the past 12 months.
What is INNO-GENE Spolka Akcyjna’s market cap?
INNO-GENE Spolka Akcyjna’s market cap is €18.48M.
When is INNO-GENE Spolka Akcyjna’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were INNO-GENE Spolka Akcyjna’s earnings last quarter?
Currently, no data Available
Is INNO-GENE Spolka Akcyjna overvalued?
According to Wall Street analysts INNO-GENE Spolka Akcyjna’s price is currently Overvalued.
Does INNO-GENE Spolka Akcyjna pay dividends?
INNO-GENE Spolka Akcyjna does not currently pay dividends.
What is INNO-GENE Spolka Akcyjna’s EPS estimate?
INNO-GENE Spolka Akcyjna’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INNO-GENE Spolka Akcyjna have?
INNO-GENE Spolka Akcyjna has 33,581,080 shares outstanding.
What happened to INNO-GENE Spolka Akcyjna’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of INNO-GENE Spolka Akcyjna?
Currently, no hedge funds are holding shares in DE:WQ3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
INNO-GENE Spolka Akcyjna
Inno-Gene SA operates a DNA research facility that deals with genetic diagnostics, research and development. The company provides services in the field of genetic medical diagnosis, including diagnosis of microbial infections and innate predispositions.